Clin2
NCT07361679Possibly a fitRecruiting

Aspirin plus heparin vs aspirin alone for preeclampsia prevention

Preeclampsia SevereToxemia Of PregnancyPreeclampsiaPregnancy ComplicationsHypertension, Pregnancy-InducedGestational Hypertension

Treatments studied

Part of Heart & circulation, Infections, Women’s health & pregnancy clinical trials.

This trial tests whether adding a daily blood-thinning injection (heparin) to low-dose aspirin helps prevent preeclampsia better than aspirin alone for pregnant women at high risk.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You are expecting a single baby (not twins or more).
  • You are less than 16 weeks pregnant.
  • You have been identified as having a high risk for preeclampsia through a first-trimester screening test.
  • You are not already taking daily aspirin for another condition, and you have no bleeding problems or past reactions to aspirin or heparin.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06468202Recruiting· Phase 4
Aspirin dose study to prevent high blood pressure in pregnancy

This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.

Birmingham, Alabama
NCT07665853Not yet recruiting· Phase 3
Aspirin to prevent preeclampsia in high-risk pregnancies

This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.

Vienna
NCT07779057Recruiting· Phase 4
Aspirin dose to prevent preeclampsia

This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.

Multan, Punjab Province
NCT05287321Recruiting· Phase 3
Aspirin plus hydroxychloroquine to prevent preeclampsia in high-risk pregnancy

This trial tests whether adding aspirin and hydroxychloroquine can lower the risk of preeclampsia during pregnancy in people considered high-risk. If you qualify, you may be assigned to take the study medicines to help protect you and the baby.

Seoul
NCT06952712Not yet recruiting· Phase 3
Aspirin 150 mg vs 100 mg to Prevent Preeclampsia in High-Risk Obese Pregnant Women

This trial tests whether a higher dose of aspirin (150 mg) works better than the standard dose (100 mg) to prevent preeclampsia, a serious pregnancy complication, in women with obesity who are at increased risk. If you are between 12 and 16 weeks pregnant with one baby and have a high BMI, you may be able to join.

Guangzhou, Guangdong
NCT06168461Recruiting· Early Phase 1
Can daily aspirin help after preeclampsia?

This study tests whether taking a low-dose aspirin every day can help improve blood vessel health in people who had preeclampsia within the past 5 years. The goal is to see if aspirin can lower the risk of future heart problems.

Iowa City, Iowa

Hear when a new Preeclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.